ONCY

#3929
Oncolytics Biotech, Inc. Common Shares
1.05 USD
+2.94%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.02
1.07
Faixa anual
0.33
1.51
Mudança diária
+2.94%
Mudança mensal
+6.06%
Mudança em 6 meses
-13.93%
Mudança anual
+81.03%
Fechamento anterior
1.02
Abrir
1.03
Bid
Ask
Mínimo
1.02
High
1.07
Volume
107
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Notícias